In the United States, sales of cannabidiol (CBD) in the e-commerce channel are forecast to increase from approximately two billion U.S. dollars in 2021 to more than six billion U.S. dollars by 2026.

It is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.

What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.

CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.

The Hemp Source CBD market has emerged as a dynamic and rapidly evolving sector within the broader cannabis industry, capturing the attention of both consumers and investors alike. With its roots deeply embedded in the use of hemp-derived cannabidiol, or CBD, this market is driven by the versatile application of CBD

Most respondents in the United States had been using cannabidiol (CBD) for a relatively short amount of time. Only 35 percent had used it for more than one year as of 2022.

The THC-free CBD oil market has rapidly evolved over the past few years, emerging as a significant segment in the broader hemp-based wellness industry. With growing awareness of the therapeutic benefits associated with cannabidiol (CBD), consumers are increasingly turning to THC-free options, which allow them to exp

The CBD oil in beauty products market has rapidly emerged as a revolutionary segment within the beauty and wellness industry, driven by growing consumer interest in natural and holistic ingredients. As awareness of the benefits of cannabidiol (CBD) expands, beauty brands are increasingly incorporating this powerful

Sales of cannabidiol (CBD) products declined by 29 percent in Nevada in the first quarter of 2022 when compared to a year ago. In comparison, sales of cannabinol (CBN) grew by 30 percent and cannabigerol (CBG) by a whopping 1,105 percent in the state over the same period.

The Cannabidiol (CBD) Vape Juice market has emerged as a dynamic and rapidly evolving sector within the larger CBD industry, which has gained significant traction due to the compound's therapeutic benefits and recreational appeal. CBD, a non-psychoactive component derived from hemp, is often lauded for its potential

Vitamins and supplements were the largest segment of the hemp based cannabidiol (CBD) market in the United States in 2023. In that year, sales of the segment reached **** million U.S. dollars. Hand and body lotions were the next largest segment at *** million dollars.

E-commerce accounted for the most sales of CBD products in the United States in 2021, by far. Over two billion U.S. dollars in sales were attributed to that channel. The next top selling channel in that year were pharmacies.

The Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market has emerged as a groundbreaking sector within the global wellness and pharmaceutical industries, driven by a surge in consumer interest and scientific research into the therapeutic benefits of cannabis-derived compounds. THC, the psychoactive component of c

The CBD Patch market has emerged as a dynamic segment within the broader cannabis industry, revolutionizing the way consumers experience the therapeutic benefits of cannabidiol. CBD patches are transdermal delivery systems infused with CBD that provide a discreet, efficient, and sustained method of administration. T

Product Market size is rising upward in the past few years And it is estimated that the market will grow significantly in the forecasted period

The Cannabidiol (CBD) market has emerged as a dynamic segment within the broader wellness and health industry, showcasing remarkable growth over the past decade. Once overshadowed by its more infamous counterpart, THC, CBD has gained recognition for its therapeutic properties, offering potential relief for a variety

Candy accounted for the vast majority of the edible CBD market in the United States in 2021. In that year, beverages made up only five percent of the market.

The CBD Oil Tincture market has emerged as a significant segment within the broader CBD industry, driven by increasing consumer awareness about the potential health benefits of cannabidiol (CBD) products. As more individuals seek natural alternatives for wellness, CBD oil tinctures have gained popularity for their c

The most commonly consumed dose of cannabidiol (CBD) among respondents in the United States in 2022 was between five and ten milligrams. Twenty-two percent of respondents either didn't know how much they consumed or did not check dosage.

The Isolate CBD Oil market has seen a significant surge in both consumer interest and product development over the past few years. Isolate CBD Oil, which is known for being the purest form of cannabidiol, contains no THC and is ideal for those seeking the benefits of CBD without the psychoactive effects associated w

Introduction

Cannabinoid Pharmaceuticals Statistics: Cannabinoid pharmaceuticals have emerged as one of the critical segments within the healthcare and wellness domains. Such development has been on consumer demand, production research, and policy change. Deriving from cannabinoids, notably CBD (cannabidiol) and THC (tetrahydrocannabinol), these drugs offer primary treatment for pain control, neurological disorders, and mental health therapies.

The article provides an in-depth analysis of key figures of Cannabinoid Pharmaceutical statistics for the year 2025 on market sizes, growth rates, regional contributions, and consumer trends.

As of 2022, 28 percent of cannabidiol (CBD) brands in the United States did not test their products for pesticide contamination. Only seven percent of brands tested all their products for contamination from pesticides, heavy metals, and microbes.